Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Klotz

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Pharmazie in Unserer Zeit|June 9, 2005
[Pharmacology of proton pump inhibitors]Ulrich Klotz
Therapeutic Drug Monitoring|December 1, 2004
Distribution of diazepam between plasma and whole bloodUlrich Klotz
Clinical Pharmacokinetics|November 22, 2007
Antiarrhythmics: elimination and dosage considerations in hepatic impairmentUlrich Klotz
Arzneimittel-Forschung|December 3, 2003
Tramadol--the impact of its pharmacokinetic and pharmacodynamic properties on the clinical management of painUlrich Klotz
Swiss Medical Weekly|April 23, 2005
Reassessment of the benefit/risk-ratio of selective COX-2-inhibitorsUlrich Klotz
Arzneimittel-Forschung|April 20, 2002
Interaction potential of lercanidipine, a new vasoselective dihydropyridine calcium antagonistUlrich Klotz
Clinical Pharmacokinetics|March 23, 2007
The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implicationsUlrich Klotz
Arzneimittel-Forschung|October 16, 2003
Pharmacological comparison of the statinsUlrich Klotz
European Journal of Clinical Pharmacology|December 12, 2007
The elderly--a challenge for appropriate drug treatmentUlrich Klotz
Drug Metabolism Reviews|June 12, 2009
Pharmacokinetics and drug metabolism in the elderlyUlrich Klotz
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Pharmazie in Unserer Zeit|June 9, 2005
[Pharmacology of proton pump inhibitors]Ulrich Klotz
Therapeutic Drug Monitoring|December 1, 2004
Distribution of diazepam between plasma and whole bloodUlrich Klotz
Clinical Pharmacokinetics|November 22, 2007
Antiarrhythmics: elimination and dosage considerations in hepatic impairmentUlrich Klotz
Arzneimittel-Forschung|December 3, 2003
Tramadol--the impact of its pharmacokinetic and pharmacodynamic properties on the clinical management of painUlrich Klotz
Swiss Medical Weekly|April 23, 2005
Reassessment of the benefit/risk-ratio of selective COX-2-inhibitorsUlrich Klotz
Arzneimittel-Forschung|April 20, 2002
Interaction potential of lercanidipine, a new vasoselective dihydropyridine calcium antagonistUlrich Klotz
Clinical Pharmacokinetics|March 23, 2007
The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implicationsUlrich Klotz
Arzneimittel-Forschung|October 16, 2003
Pharmacological comparison of the statinsUlrich Klotz
European Journal of Clinical Pharmacology|December 12, 2007
The elderly--a challenge for appropriate drug treatmentUlrich Klotz
Drug Metabolism Reviews|June 12, 2009
Pharmacokinetics and drug metabolism in the elderlyUlrich Klotz
Pageof 6